VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ASPNAspen Aerogels, Inc.
$5.63$467M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
  1. Home
  2. Financial Ratios

  1. Home
  2. Stocks
  3. ASPN
  4. Financial Ratios

Aspen Aerogels, Inc. (ASPN) Financial Ratios

Latest Ratios: P/E Ratio -1.2x · EV/EBITDA N/A · ROE -91.6%. (2009–2025 historical series)

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly

ASPN Valuation Multiples

Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Market Cap$467M$234M$954M$1.1B$464M$1.5B$440M$187M$51M$114M$96M
Enterprise Value$453M$221M$931M$1.1B$302M$1.5B$432M$192M$51M$107M$78M
P/E Ratio →-1.19—69.88————————
P/S Ratio1.720.862.114.592.5712.464.391.340.481.020.81
P/B Ratio1.980.991.552.251.0411.806.493.170.721.130.83
P/FCF———————————
P/OCF14.197.1220.95————————

P/E links to full P/E history page with 30-year chart

ASPN EV Ratios

Enterprise-value multiples — capital-structure-neutral measures of total business value

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
EV / Revenue—0.812.064.591.6811.954.311.380.490.960.66
EV / EBITDA——11.79————————
EV / EBIT—0.0434.40————————
EV / FCF———————————

ASPN Profitability

Margins and return-on-capital ratios measuring operating efficiency

Margins

Full margin charts and quarterly trend are on the Earnings History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Gross Margin17.0%17.0%40.4%23.8%2.8%8.2%14.6%18.9%12.1%16.7%19.8%
Operating Margin-19.0%-19.0%12.0%-20.6%-43.9%-33.4%-21.5%-10.2%-32.5%-17.1%-9.5%
Net Profit Margin-143.7%-143.7%3.0%-19.2%-45.9%-30.5%-21.7%-10.5%-33.0%-17.3%-10.2%

Return on Capital

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
ROE-91.6%-91.6%2.4%-9.8%-28.7%-37.8%-34.4%-22.5%-40.2%-17.8%-10.1%
ROA-59.8%-59.8%1.7%-6.8%-20.0%-26.5%-21.7%-14.4%-30.9%-14.9%-8.8%
ROIC-9.5%-9.5%7.6%-9.6%-33.7%-48.0%-26.2%-15.7%-30.8%-15.0%-9.0%
ROCE-9.1%-9.1%7.7%-8.3%-22.3%-35.3%-27.6%-19.0%-38.1%-17.5%-9.4%

ASPN Leverage & Debt

Solvency and debt-coverage ratios — lower is generally safer

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Debt / Equity0.610.610.320.280.270.120.120.140.060.040.00
Debt / EBITDA——2.50————————
Net Debt / Equity—-0.06-0.04-0.00-0.36-0.48-0.120.080.01-0.07-0.16
Net Debt / EBITDA——-0.30————————
Debt / FCF———————————
Interest Coverage0.940.942.26-7.60-15.19-160.98-89.87-34.87-64.73-103.44-76.33

Net cash position: cash ($157M) exceeds total debt ($144M)

ASPN Liquidity & Efficiency

Short-term solvency ratios and asset-utilisation metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Current Ratio3.903.903.723.414.683.073.381.501.612.212.77
Quick Ratio3.293.293.292.914.402.742.441.221.301.802.06
Cash Ratio2.532.532.011.793.562.091.180.120.140.501.00
Asset Turnover—0.670.510.340.280.661.031.351.050.900.87
Inventory Turnover5.895.895.674.647.789.326.5412.9012.5310.437.34
Days Sales Outstanding—47.4987.97107.02116.0661.3057.1484.4789.4187.5154.36

ASPN Shareholder Yields

Earnings, FCF, buyback, and dividend yields — total returns to shareholders

Dividends

Full dividend history and growth charts are on the Dividend History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Dividend Yield———————————
Payout Ratio———————————

Total Shareholder Return Metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Earnings Yield——1.4%————————
FCF Yield———————————
Buyback Yield0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%1.1%0.3%0.2%
Total Shareholder Yield0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%1.1%0.3%0.2%
Shares Outstanding—$83M$80M$69M$39M$30M$26M$24M$24M$23M$23M

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetAdequate
Cash FlowMixed
Top Statement Risk

Manufacturing scale-up execution risk

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Market Pricing Reflects Speculative Pivot

Based on current market data, the company trades at a price-to-sales ratio of 1.72, which suggests that investors are pricing the firm as a speculative growth option on EV safety mandates rather than a traditional industrial manufacturer with established, predictable earnings streams or consistent historical profitability.

The absence of a meaningful P/E ratio and the forward EV/EBITDA of 27.82 indicate that the market is heavily discounting current losses in anticipation of future scale. This valuation appears to hinge entirely on the successful conversion of long-term OEM supply agreements into high-margin revenue, a scenario that remains unproven given the recent contraction in top-line performance.

Capital Efficiency Remains Severely Impaired

As reported in recent financial statements, the company's ROIC has fluctuated significantly, reaching a negative 7.9% in 2026Q1, which underscores the difficulty of generating adequate returns on the substantial capital deployed toward the Georgia manufacturing facility during this ongoing and volatile strategic transition period.

The erratic nature of these returns suggests that the firm is currently in a capital-intensive phase where asset utilization is insufficient to cover the cost of investment. Investors should monitor whether the company can achieve positive, sustainable returns on invested capital as the EV thermal barrier segment matures and moves beyond the initial ramp-up phase.

Working Capital Cycles Signal Inefficiency

According to quarterly data, the cash conversion cycle has expanded to 142 days in 2026Q1, reflecting a deterioration in working capital efficiency that appears driven by elevated inventory levels and extended collection periods compared to the more streamlined operational cycles observed in the 2024 fiscal year.

The increase in days inventory outstanding to 93 days suggests potential challenges in aligning production output with actual customer demand in the EV segment. This inefficiency ties up critical liquidity, forcing the company to rely more heavily on its cash reserves to fund operations while waiting for inventory to convert into realized revenue.

Liquidity Runway Supports Operational Pivot

Based on the most recent balance sheet, the company maintains a current ratio of 2.88, which provides a necessary buffer to navigate the current period of negative operating margins and significant capital expenditures associated with the ongoing expansion of its specialized aerogel manufacturing capabilities in Georgia.

While the liquidity position appears adequate for the near term, the reliance on cash reserves to offset operational burn warrants close monitoring. The company's ability to maintain this liquidity without further dilutive financing will depend on its success in stabilizing gross margins and accelerating the throughput of its high-growth EV product lines.

Misapplication of Standard P/E Multiples

The price-to-earnings ratio is the most commonly misapplied metric for this business model, as it obscures the company's current status as a pre-commercialization growth entity where heavy R&D and CAPEX investments intentionally suppress net income to build long-term competitive advantages in the EV thermal barrier market.

Using P/E to evaluate this firm ignores the non-cash charges and strategic investments that currently distort the bottom line. Analysts should instead focus on metrics like EV/Revenue or the growth in design-ins for the PyroThin product line, which better capture the underlying value of the company's proprietary technology and its potential as a regulatory hedge for automotive OEMs.

Download Financial Ratios Data

Includes 30+ ratios · 16 years · Updated daily

Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

ASPN — Frequently Asked Questions

Quick answers to the most common questions about buying ASPN stock.

What is Aspen Aerogels, Inc.'s P/E ratio?

Aspen Aerogels, Inc.'s current P/E ratio is -1.2x. The historical average is 69.9x.

What is Aspen Aerogels, Inc.'s ROE?

Aspen Aerogels, Inc.'s return on equity (ROE) is -91.6%. The historical average is -62.6%.

Is ASPN stock overvalued?

Based on historical data, Aspen Aerogels, Inc. is trading at a P/E of -1.2x. Compare with industry peers and growth rates for a complete picture.

What are Aspen Aerogels, Inc.'s profit margins?

Aspen Aerogels, Inc. has 17.0% gross margin and -19.0% operating margin.